UVEAL MELANOMA, RECURRENT
Clinical trials for UVEAL MELANOMA, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new UVEAL MELANOMA, RECURRENT trials appear
Sign up with your email to follow new studies for UVEAL MELANOMA, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested for rare, spreading eye cancer
Disease control Recruiting nowThis study is testing a new oral drug called NBM-BMX for people with metastatic uveal melanoma, a rare type of eye cancer that has spread. The main goals are to find a safe and effective dose, learn about side effects, and see if the drug can shrink or slow the growth of tumors. …
Matched conditions: UVEAL MELANOMA, RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New cancer drug injected directly into tumors enters human testing
Disease control Recruiting nowThis is a first-in-human study to find a safe and effective dose of a new drug called ONM-501. The drug is injected directly into tumors and is being tested alone and in combination with an approved immunotherapy drug (cemiplimab) in adults with advanced cancers that have stopped…
Matched conditions: UVEAL MELANOMA, RECURRENT
Phase: PHASE1 • Sponsor: OncoNano Medicine, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC